Product Information
TRAVATAN Z 0.004% EYE DROP is a brand product labeled by Sandoz Inc., priced at $94.2984 per ML under NDC 66758009575. Its NADAC has been published 100 times since Nov 6, 2024.
FDA first approved this application on Sep 21, 2006. Its Orange Book therapeutic-equivalence code is AT2.
Strength
.04 mg/mL
Manufacturer
Sandoz Inc.NDC
66758009575
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TRAVOPROSTApproval Type
New Drug (NDA)
FDA Application
NDA021994FDA Approved
9/21/2006
TE Code
AT2
On Market Since
10/20/2006
Pharmacological Classes
Price Statistics
The NADAC for TRAVATAN Z 0.004% EYE DROP has been published 100 times since Nov 6, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $94.2984 per ML |
|---|---|
| All-time high | $94.5660 (Jan 15, 2025) |
| All-time low | $94.2984 (Sep 23, 2026) |
| 52-week high | $94.4898 |
| 52-week low | $94.2984 |
| Median price | $94.4419 |
| Average price | $94.4318 |
| Largest weekly change | -0.2% (Jan 22, 2025) |
| Weeks tracked | 100 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
travoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRAVATAN Z 0.004% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TRAVATAN Z 0.004% EYE DROP, manufactured by Sandoz Inc., is $94.2984 per ML (NDC 66758009575), effective Sep 30, 2026.
How has the price of TRAVATAN Z 0.004% EYE DROP changed over time?
Over the history we have for it, the NADAC for TRAVATAN Z 0.004% EYE DROP has held within roughly two percent of its current level. It has been tracked across 100 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for TRAVATAN Z 0.004% EYE DROP?
Since Nov 6, 2024, the NADAC for TRAVATAN Z 0.004% EYE DROP has ranged from a low of $94.2984 (Sep 23, 2026) to a high of $94.5660 (Jan 15, 2025), with a median of $94.4419 per ML.
Are there cheaper alternatives to TRAVATAN Z 0.004% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAVATAN Z 0.004% EYE DROP, is $94.2313 per ML — about 0% below TRAVATAN Z 0.004% EYE DROP.
Who manufactures TRAVATAN Z 0.004% EYE DROP?
TRAVATAN Z 0.004% EYE DROP (NDC 66758009575) is labeled by Sandoz Inc., and CMS classifies it as a brand product.